Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03902184
Title IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma (TELLOMAK)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Innate Pharma
Indications

anaplastic large cell lymphoma

mycosis fungoides

Sezary's disease

angioimmunoblastic T-cell lymphoma

peripheral T-cell lymphoma

Therapies

Gemcitabine + Lacutamab + Oxaliplatin

Lacutamab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.